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A B S T R A C TObjectives: To evaluate the performance of the Mental Component
of the Short-Form 12 Health Survey, Version 1(SF-12v1), as a screen-
ing measure of depressive disorders. Methods: Data come from the
European Study of the Epidemiology of Mental Disorders (ESEMeD), a
cross-sectional survey carried out on representative samples of
21,425 individuals from the noninstitutionalized adult general pop-
ulation of six European countries (response rate ¼ 61.2%). The SF-12
was administered and scored according to three algorithms: the
‘‘original’’ method (mental component summary of SF-12 [MCS-12]),
the RAND-12 (RAND-12 Mental Health Composite [RAND-12 MHC]),
and the Bidemensional Response Process Model 12 mental health
score (BRP-12 MHS), based on a two-factor Item Response Theory
graded response model. Thirty-day and 12-month depressive dis-
orders (major depressive episode or dysthymia) were assessed with
the Composite International Diagnostic Interview, Version 3.0, by
using Diagnostic and Statistical Manual of Mental Disorders, Fourth
Edition criteria. Receiver operating characteristic curves analysis
was carried out, and optimal cutoff points maximizing balance
between sensitivity (SN) and specificity (SP) were chosen for the
three methods. Results: Prevalence of 30-day and 12-monthsee front matter Copyright & 2013, International
r Inc.
.1016/j.jval.2013.01.006
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al Research Park, Doctor Aiguader, 88 – 08003 Bardepressive disorders in the overall sample was 1.5% and 4.4%,
respectively. The area under the curve for 30-day depressive disorders
was 0.92, and it decreased to 0.85 for 12-month disorders, regardless of
the scoring method. Optimal cutoff for 30-day depressive disorders was
45.6 (SN ¼ 0.86; SP ¼ 0.88) for the MCS-12, 44.5 for the RAND-12 MHC
(SN ¼ 0.87, SP ¼ 0.86), and 40.2 for the BRP-12 MHS (SN ¼ 0.87,
SP ¼ 0.87). The selected 12-month cutoffs for MCS-12 and RAND-12
MHC were between 4.2 and 5.8 points below the general population
means of each country, with SN range 0.67 to 0.78 and SP range 0.77
to 0.87. Conclusions: The SF-12 yielded acceptable results for detecting
both active and recent depressive disorders in general population
samples, suggesting that the questionnaire could be used as a useful
screening tool for monitoring the prevalence of affective disorders and
for targeting treatment and prevention.
Keywords: depressive disorders, diagnostic accuracy, health-related
quality-of-life, mental health screeming, mental disorders, screening,
SF-12.
Copyright & 2013, International Society for Pharmacoeconomics and
Outcomes Research (ISPOR). Published by Elsevier Inc.Introduction
The Short-Form 12 Health Survey, Version 1 (SF-12v1), is a generic
health-related quality-of-life instrument. It was originally devel-
oped in 1994 as a shorter alternative (12 items) to the widely used
Short-Form 36 Health Survey (SF-36), for studies in which a 36-item
form was too long. The mental health dimension of the SF-36 is
composed of the 5 items of the Mental Health Inventory , which has
shown good performance in tests of sensitivity (SN) and specificity
(SP) relative to other screening tools for depression and other
mental disorders [1]. Three of the five items of the Mental Health
Inventory are still included in the SF-12 and refer to symptoms
related to the diagnostic criteria for common depressive andanxiety disorders. Furthermore, the questionnaire includes other
items regarding functional impairment due to mental problems
that are also related to experiences of distress or impairment as a
consequence of psychological symptoms, which need to be fulfilled
according to both Diagnostic and Statistical Manual of Mental Disorders,
Fourth Edition (DSM-IV) [2] and International Statistical Classification of
Diseases, 10th Revision (ICD-10) [3] classification systems. As a brief
and reliable measure of overall health status, the SF-12 health
questionnaire is often included in large population health surveys.
Moreover, given its content, the mental component of the SF-12
could serve as a screener of depressive disorders [4] and thus it
could be useful for monitoring prevalence [5] and for targeting
treatment and prevention [6].Society for Pharmacoeconomics and Outcomes Research (ISPOR).
arch Unit, IMIM (Hospital del Mar Medical Research Institute),
celona, Spain.
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disorders in the general population, however, has been scarcely
studied. To our knowledge, only one study has assessed its
diagnostic accuracy, reporting an area under the curve (AUC) of
0.92 to predict major depression [4]. Even though these authors
provide cutoff points of the SF-12 for the Australian general
population, the question is whether these cutoff points are
adequate for Europe.
The items of the SF-12 were selected to reproduce the two
summary measures, Physical Component Summary (PCS) and
Mental Component Summary (MCS), of the SF-36. The SF-12
scoring method proposed by Ware et al. [7] assumes that each
item contributes to both physical component summary and
mental component summary (MCS-12) and that these two meas-
ures are uncorrelated. This scoring method, however, does not
necessarily optimize the information contained within the items.
Alternative scoring methods for the SF-12 have been proposed:
the RAND-12 Health Status Inventory [8] and the Bidemensional
Response Process Model algorithm (BRP-12) based on the Item
Response Theory (IRT) [9] (Forero et al., under review). The scores
derived from the RAND-12 represent composite estimates of the
corresponding RAND-36 Health Status Inventory Physical Health
Composite and Mental Health Composite (MHC). The RAND-36
and RAND-12 algorithms avoid item ambiguities by letting the
items load on just one factor, but factors are allowed to correlate
by means of an oblique rotation method. Thus, in the RAND-12,
six of the items contribute to the Physical Health Composite and
the remaining ones to the MHC dimensions [8]. Conversely, the
BRP-12 scoring is based on a two-factor IRT Graded Response
Model [10] directly applied to the SF-12 items, where all items are
allowed to load on both dimensions, much in the fashion of the
SF-12 MCS-12, and the correlation between both dimensions is
set to 0. Differently from the classical SF-12 and the RAND-12
models, BRP-12 scores do not serve as a surrogate measure for
the 36-item versions and all information is extracted from the 12
items. Scores obtained with weighted combinations of the same
items are expected to be highly correlated; however, different
weights have great impact on model reliability. As an IRT model,
the BRP-12 mental health score (MHS) obtains a set of weights
that maximizes reliability [11]. In our case, the BRP-12 MHS is
more reliable than the MCS-12 and the RAND-12 MHC in terms of
model-based internal consistency reliability (the proportion of
observed variance attributable to the factor model underlying the
score) [12], with a value of 0.77 for the BRP-12 MHS, as compared
with the obtained values of 0.66 for the MCS-12 and 0.67 for the
RAND-12 MHC. It is not clear, however, whether the screening
accuracy of the instrument for depressive disorders differs
according to the scoring method [9] (Forero, under review).
In the present study, we aimed to evaluate the performance of
the SF-12 to detect depressive disorders in the general population.
We compared classification abilities of three scoring methods
(MCS-12, RAND-12 MHC, and BRP-12 MHS) by using data from a
representative sample from the general population of six Euro-
pean Countries [13]. Results were obtained both for the whole
European sample and by country. In addition, we aimed to
estimate the best cutoff point for each of the proposed methods
for screening purposes of depressive disorders in Europe.Methods
Sample Description
Data come from the European Study of the Epidemiology of
Mental Disorders (ESEMeD) project, a cross-sectional survey
conducted in six European countries to study the prevalence
and correlates of mental disorders.The methods used for data collection have been described
elsewhere [13]. Briefly, a stratified, multistage, clustered area
probability sample of noninstitutionalized adult population (aged
18 years or older) in Belgium, France, Germany, Italy, The Nether-
lands, and Spain was selected. The questions were administered
by trained lay interviewers at the respondent’s house between
January 2001 and August 2003 by using computer-assisted per-
sonal interview techniques. The total sample size achieved was
21,425 individuals, with an overall weighted response rate of
61.2%, ranging from 45.9% in France to 78.6% in Spain.
Measures
Mental Disorders
Mental disorders were assessed by using version 3.0 of the World
Health Organization Composite International Diagnostic Inter-
view (CIDI 3.0) [14], a fully structured lay administered diagnostic
interview designed to assess the presence of most common
mental disorders following the definitions and criteria of both
the DSM-IV [2] and the ICD-10 [3] classification systems. Here we
consider the DSM-IV diagnostics of common disorders of the
depressive spectrum (major depression episode or dysthymia).
We assessed whether respondents fulfilled criteria for these
disorders any time in the previous 30 days (30-day disorders)
and 12 months (12-month disorders). We decided to look at the
two recall periods to determine whether the SF-12 questionnaire
was sensitive to both active and recent episodes, even though the
disorder may not be present anymore at the interview time.
A clinical reappraisal study with blinded clinical follow-up
interviews using the Structured Clinical Interview for DSM-IV [15]
in several surveys (France, Italy, Spain, US) found generally good
concordance between diagnoses based on the CIDI 3.0 and those
based on the Structured Clinical Interview for DSM-IV [16].
The SF-12
SF-12v1 was used because version 2 was not available when the
ESEMeD surveys were designed. The standard form, with a recall
period of 4 weeks in most of the items but three, was adminis-
tered to all respondents. We focus on the mental summary
measure of the SF-12, which has been obtained following two
already available scoring methods: the ‘‘original’’ MCS-12 scores
proposed by Ware et al. [7] and the RAND-12 MHC proposed by
Hays [8].
The MCS-12 score is calculated by using US-derived item
weights for response categories following recommendations
from the authors of the instrument (which were done after
having assessed the equivalence between country-specific and
US weights in nine countries including most of the countries
evaluated here) when international comparisons are to be con-
ducted [17,18]. The weights to be applied are the coefficients of a
linear regression model that was estimated on a representative
sample of the US general population to predict the MCS of the
SF-36 from a set of dummy variables defining all but one item
response categories of each of the 12 items of the SF-12. The
RAND-12 MHC, in turn, also applies response category weights
that were obtained from one-parameter IRT models on each of
the eight RAND-36 scales. Moreover, additional scoring weights,
obtained from a linear regression model of the RAND-36 MHC
composite on six IRT- weighted items that contribute to the
mental score, were applied to each item. Both the MCS-12 and
the RAND-12 MHC use norm-based scoring, where the mental
summary measures have a mean of 50 and an SD of 10 in the US
general population and scores greater (lower) than 50 reflect
better (worse) mental health status than the US general
population.
An alternative scoring method for the SF-12 has been proposed
[9] (Forero et al., under review) and is applied here, the BRP-12.
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multidimensional Graded Response Model to SF-12 items [10],
where items define two uncorrelated latent traits (physical and
mental) to explain the individual response process. The distinc-
tive feature of the BRP-12 model is that all items are indicators of
both dimensions, so that item responses depend on the individual
location on both health factors. This model yields good results in
terms of fit (root mean square error of approximation ¼ 0.057;
comparative fit index ¼ 0.95; Tucker Lewis index ¼ 0.94) and
overall model-based internal-consistency reliability [12] of 0.77 for
the MHS. Model estimation of the BRP-12 was conducted by using
Marginal Maximum Likelihood via the Expectation-Maximization
algorithm. Individual scores were computed as Expected a Posteriori
[19] estimates of the latent trait (i.e., mental health factor) person
parameter of each individual and transformed into T scores, with
an average of 50 and an SD of 10 in our sample. Higher scores are
indicative of better mental health status.Statistical analysis
The 30-day and 12-month prevalence of depressive disorders was
estimated for the overall sample and for each country separately.
Mean values and 95% confidence interval (CI) of the mental
scores of the SF-12 using the three scoring methods were also
obtained for the overall sample and for each country.
The discriminant validity of the three scoring methods for
each target diagnosis was assessed with the receiver operating
characteristic (ROC) curves that graph the SN against the false-
positive rate (1  SP) of every possible value of the scale. Non-
parametric methods were used to calculate the AUCs and
corresponding 95% CIs of each scoring method for each diagnosis
of interest. The AUC evaluates discrimination ability and can be
interpreted as the probability that a randomly selected case
according to the CIDI will score higher on the mental component
of the SF-12 than will a randomly selected noncase [20]. AUC
values range from 0.5 to 1.0. It takes the value 0.5 when no
discrimination exists, that is, the scale is performing at a chance
level, and 1.0 when there is perfect discrimination. It has been
suggested that AUC values from 0.5 to 0.7 represent rather lowFig. 1 – Thirty-day and 12-month prevalence of depressive disor
depressive disorders (in black), 30-day depressive disorders (in
*Depressive disorders: major depression episode or dysthymiadiscrimination ability, between 0.7 and 0.9 correspond to moder-
ate discrimination ability, and values greater than 0.9 are con-
sidered as high [21].
Screening cutoff points on each of the three scoring methods
were selected to detect 30-day and 12-month depressive disor-
ders. The best cutoff point was selected on the basis of empirical
Youden Index, that is, the observed value that maximizes SN þ
SP – 1. This index has been suggested as a summary measure
that assumes that both SN and SP are equally important [22].
The SN (the percentage of true cases correctly classified by a
certain cut point of the SF-12), SP (the percentage of true noncases
correctly classified) [22], positive likelihood ratio (the probability of
a person who has the disease testing positive divided by the
probability of a person who does not have the disease testing
positive), and negative likelihood ratio (the probability of a person
who has the disease testing negative divided by the probability of a
person who does not have the disease testing negative) were
obtained for the selected cutoff points [23]. The diagnostic odds
ratio (DOR) and the AUC of the SF-12 measures dichotomized at
the selected thresholds to predict the presence of the mental
disorders of interest were also calculated. Although the AUC was
originally developed to study the association between a continu-
ous predictor and a dichotomous outcome, the AUC can be used
when the predictor is a dichotomous variable, in which special
case AUC equals (SN þ SP)/2. The AUC has been selected over the
more popular individual-level concordance statistic Cohen’s
Kappa (k) because the latter depends on prevalence and conse-
quently is often low in situations in which there appears to be
high agreement between low-prevalence measures [24].
The analysis regarding 12-month depressive disorders was
stratified by country. Results for 30-day diagnostic were carried out
only for the overall sample because of the low number of individuals
with active depressive disorders within each of the countries.
All analyses were conducted in SASTM software, version 9.0, of
the SAS system for windows [25], and SUDAAN software, version
10.0 [26]. Individuals were weighted to account for the different
probabilities of selection as well as to restore age and gender
distribution of the population within each country and the
relative dimension of the population across countries. Theders* in the total ESEMeD sample and by country. 12-month
white).
based on DSM-IV criteria as assessed with the CIDI 3.0.
Fig. 2 – Mean values (95% CI) of the mental component of the SF-12 in the ESEMeD sample, according to scoring method* and
country. ESEMeD sample. MCS-12y (black diamonds), RAND-12 MHCz (grey squares), BRP-12 MHSy (white circles).
*MCS-12 and RAND-12 MHC use norm-based scoring with Mean ¼ 50 and Standard deviation ¼ 10 in the US General
Population; BRP-12 scores were transformed to T metric with a mean ¼ 50 and Standard Deviation ¼ 10 in the ESEMeD
sample.
yMCS-12: Original Mental Component Summary.
zRAND-12 MHC: RAND-12 Mental Health Composite.
yBRP-12 MHS: Bidimensional Response Process model Mental Health Score.
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complex sample design by using the Taylor series linearization
method.Results
The mean age of the sample was 47.1 (SD ¼ 29.3) years, with most
individuals in the category of 35 to 49 years of age and 20% of the
sample older than 65 years. Fifty-two per cent of them were
female, and 67% were married or cohabiting. Over one-third of
the sample had received more than 12 years of education [13].Table 1 – Areas under the curve (AUCs) for the mental com
according to scoring method and country.
Disorder Country
30-d depressive disorders Overall sample 0
12-mo depressive disorders Overall sample 0
Belgium 0
France 0
Germany 0
Italy 0
The Netherlands 0
Spain 0
BRP-12 MHS, Bidimensional Response Process Model Mental Health Score
DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, Fourth Editio
RAND-12 Mental Health Composite; SE, standard error; SF-12v1, Short-F
Depressive disorders: major depression episode or dysthymia based onDepressive disorders in the past 30 days were present in 1.5%
of the sample, with values across countries ranging from 1.1%
(Germany) to 1.9% (Spain). The prevalence of 12-month depres-
sive disorders in the total sample was 4.4%, and there were
significant differences across countries, from 6.5% in France to
3.4% in Italy and 3.3% in Germany. A prevalence of around 5% was
found in Belgium and The Netherlands and 4.4% in Spain (Fig. 1).
Mean scores and 95% CIs for the three scoring methods are
presented in Figure 2. Mean MCS-12 score was 53.7 in the entire
sample, almost 4 points higher than in the US general popula-
tion, which is fixed to 50 [7]. Mean scores varied significantly
across countries, with France being the country with the lowestponent of the SF-12v1 against depressive disorders,
AUC (SE)
MCS-12 RAND-12 MHC BRP-12 MHS
.93 (0.01) 0.92 (0.01) 0.92 (0.01)
.85 (0.01) 0.85 (0.01) 0.85 (0.01)
.83 (0.02) 0.83 (0.02) 0.84 (0.02)
.81 (0.02) 0.82 (0.02) 0.82 (0.02)
.88 (0.02) 0.89 (0.02) 0.89 (0.02)
.86 (0.02) 0.86 (0.02) 0.86 (0.02)
.86 (0.02) 0.86 (0.02) 0.87 (0.02)
.84 (0.02) 0.85 (0.02) 0.85 (0.02)
; CIDI 3.0, Composite International Diagnostic Interview Version 3.0;
n; MCS-12, Original Mental Component Summary; RAND-12 MHC,
orm 12 Health Survey Version 1.
DSM-IV criteria as assessed with the CIDI 3.0.
VA L U E I N H E A LT H 1 6 ( 2 0 1 3 ) 5 6 4 – 5 7 3568(worst) scores (mean ¼ 52.6). Conversely, Belgium, Germany, and
The Netherlands showed the highest scores, with mean values
near 54.4. Scores for the RAND-12 MHC were significantly lower
than for MCS-12 in most of the countries, with a mean value of
52.9 for the overall sample. The BRP-12 scores were transformed
into the T metric (mean ¼ 50, SD ¼ 10).
The rank order correlations among the three scoring methods
ranged between 0.89 and 0.97, the correlation between the MCS-
12 and the RAND-12 MHC being the lowest and the correlation
between the BRP-12 and the RAND-12 being the highest. These
results were consistent across countries (results not shown but
available under request).
Table 1 presents the AUC for the three scoring methods
against 30-day and 12-month depressive disorders for the overall
sample. The AUC value for 30-day depressive disorders was high,
above 0.92 according to the three scoring methods, while it
decreased to a moderate value of 0.85 for 12-month depressive
disorders. There were no statistically significant differences
between the AUCs of the three scoring methods for both the
30-day and the 12-month assessments. With regard to the
comparison between countries, the AUC for 12-month depressive
disorders was higher in Germany (around 0.89), Italy, and The
Netherlands (0.86 for the three methods) than in Belgium (around
0.83) and France (above 0.82 for the three scoring methods). AUC
values for major depression episode were very similar to those of
depressive disorders, with high values of 0.93 for 30-day and
moderate values of 0.85 for 12-month depressive disorders in the
whole sample (results not shown but available under request).
The ROC curves for the diagnosis of depressive disorders
according to the three scoring methods are presented in Figure 3,
separately for 30-day (Fig. 3A) and 12-month (Fig. 3B) recall periods.
The shapes of the ROC curves showed that none of the scoring
methods had consistently higher SN and SP than the others.
As shown in Table 2, the best screening cut point for MCS-12
to evaluate 30-day depressive disorders was 45.6, with SN ¼ 0.86
(0.02) and SP ¼ 0.88 (0.003), which lead to a positive likelihood
ratio of 6.9 (95% CI 6.5–7.3) and a negative likelihood ratio of 0.2
(95% CI 0.1–0.2). The cutoff point of 44.5 for the RAND-12 MHC
and 40.2 for the BRP-12 provided similar values of SN and SP. A
score of 48.9 was chosen as the best screening cutoff point for the
MCS-12 against 12-month depressive disorders, with SN ¼ 0.74
and SP ¼ 0.83. The best cutoff point chosen for the RAND-12 MHC
was 47.9, with an SN of 0.77 and an SP of 0.79 for the whole
sample. For the BRP-12 score, the selected cutoff point that
provided best trade-off between SN and SP was 41.9, with similar
SN as the MCS-12 (0.73) but slightly higher SP (0.84).
There were statistically significant differences across coun-
tries with regard to the sensitivities and specificities achieved by
the suggested cutoff point to screen for 12-month depressive
disorders according to the three scoring methods (Table 3).
Sensitivities for the MCS-12 ranged from 0.67 in The Netherlands
to 0.78 in Germany, and SP values ranged from 0.79 in France and
Spain to 0.87 in The Netherlands.Fig. 3 – ROC curves for 30-day (3a) and 12-month (3b)
depressive disorders, according to scoring method. ESEMeD
sample. AUC: Area Under the Curve.
*MCS-12: Original Mental Component Summary.
yRAND-12 MHC: RAND-12 Mental Health Composite.
zBRP-12: Bidimensional Response Process model Mental
Health Score.Discussion
This study evaluated the screening performance of the mental
component of the SF-12 to identify individuals with depressive
disorders, using data from representative samples of the adult
populations of six European countries. The performance of the
original scoring method of the SF-12, proposed by Ware et al. [7],
was compared with that of two alternative scoring methods, the
RAND-12 [6] and the BRP-12 [9] (Forero et al., under review). The
results show AUCs around 0.92 for 30-day disorders, accuracy
comparable to that of other widely used specific screening
measures [27,28]. The AUC for 12-month depressive disorders,as expected, is a little lower but still high (around 0.85). This
suggests that beyond the usual applications of the SF-12, this
short questionnaire could be a useful screening tool for the
assessment of affective disorders in general population surveys,
such as Health Interview Surveys, in which this instrument is
often included.
No statistically significant differences are found across the three
scoring methods that have been compared in terms of accuracy to
detect depressive disorders. The scoring method suggested by
Farivar et al. [29] has been additionally tested providing similar
results to the other three, with an AUC value of 0.93 (0.01). This
Table 2 – Accuracy of the SF-12v1 for depressive disorders (30-d and 12-mo) at selected cutoff points according to scoring method, in the ESEMeD
sample.
Scoring
method and
cut point
Prevalence
SF-12y
Prevalence
depressive
disorders
Sensitivity
(SN)
Specificity
(SP)
LRþ LR Design-
adjusted
odds ratio
Design-
adjusted
AUCz
% SE % SE SN SE SP SE LRþ Low Upp LR Low Upp OR Low Upp AUC SE
30-d
depressive
MCS-12 r 45.6 13.5 0.3 1.5 0.1 0.86 0.02 0.88 0.003 6.9 6.5 7.3 0.2 0.1 0.2 42.0 29.7 59.5 0.87 0.01
disorders RAND-12
MHC r 44.5
15.3 0.4 1.5 0.1 0.87 0.02 0.86 0.004 6.1 5.8 6.4 0.2 0.1 0.2 39.2 27.7 55.4 0.86 0.01
BRP-12
MHS r 40.2
14.2 0.4 1.5 0.1 0.87 0.02 0.87 0.003 6.6 6.3 7.0 0.2 0.1 0.2 42.9 29.8 61.6 0.87 0.01
12-mo
depressive
MCS-12 r 48.9 19.5 0.4 4.3 0.2 0.74 0.02 0.83 0.004 4.3 4.1 4.5 0.3 0.3 0.4 13.5 11.1 16.4 0.78 0.01
disorders RAND-12
MHC r 47.9
23.1 0.5 4.3 0.2 0.77 0.02 0.79 0.005 3.7 3.5 3.9 0.3 0.3 0.3 12.5 10.2 15.4 0.78 0.01
BRP-12
MHS r 41.9
18.0 0.4 4.3 0.2 0.73 0.02 0.85 0.004 4.7 4.5 5.0 0.3 0.3 0.4 15.0 12.4 18.1 0.79 0.01
Note. Estimates and standard errors (SEs) or 95% confidence interval.
AUC, area under the curve; BRP-12 MHS, Bidimensional Response Process Model Mental Health Score; CIDI 3.0, Composite International Diagnostic Interview, Version 3.0; DSM-IV, Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition; ESEMeD, European Study of the Epidemiology of Mental Disorders; Low, lower limit 95% confidence interval; LRþ, positive likelihood ratio; LR,
negative likelihood ratio; MCS-12, Original Mental Component Summary; RAND-12 MHC, RAND-12 Mental Health Composite; SE, standard error; SF-12v1, Short-Form 12 Health Survey, Version
1; Upp, upper limit 95% confidence interval.
Depressive disorders: major depression episode or dysthymia based on DSM-IV criteria as assessed with the CIDI 3.0.
yPrevalence according to the SF-12 with the selected cutoff point.
zAUC for a dichotomous predictor (1 ¼ below or equal to the cutoff point; 0 ¼ above the cutoff point).
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Table 3 – Accuracy of the SF-12v1 for depressive disorders (30-d and 12-mo) at selected cutoff points according to scoring method and country, in the
ESEMeD sample.
Scoring method
and cut point
Country Prevalence
SF-12y
Prevalence
depressive
disorders
Sensitivity
(SN)
Specificity
(SP)
LRþ LR Design-
adjusted
odds ratio
Design-
adjusted AUCz
% SE Est SE Est SE Est SE LRþ Low Up LR Low Up OR Low Up AUC SE
MCS-12 r 48.9 Belgium 17.1 1.2 5.3 0.6 0.68 0.05 0.86 0.01 4.7 4.1 5.5 0.4 0.3 0.5 12.5 7.4 21.2 0.77 0.03
France 23.6 1.0 6.5 0.6 0.70 0.04 0.80 0.01 3.5 3.1 3.9 0.4 0.3 0.5 9.3 6.3 13.8 0.75 0.02
Germany 15.7 0.9 3.3 0.4 0.78 0.04 0.86 0.01 5.7 5.1 6.5 0.3 0.2 0.4 22.6 14.1 36.3 0.82 0.02
Italy 20.0 0.7 3.4 0.3 0.77 0.04 0.82 0.01 4.3 3.8 4.7 0.3 0.2 0.4 14.9 9.6 23.3 0.79 0.02
The Netherlands 15.5 0.9 5.1 0.6 0.67 0.05 0.87 0.01 5.2 4.4 6.2 0.4 0.3 0.5 13.9 8.5 22.9 0.77 0.03
Spain 23.3 0.9 4.4 0.3 0.74 0.03 0.79 0.01 3.5 3.2 3.9 0.3 0.3 0.4 10.9 7.6 15.5 0.77 0.02
RAND-12 Belgium 19.7 1.3 5.3 0.6 0.71 0.05 0.83 0.01 4.2 3.6 4.9 0.4 0.3 0.5 11.9 7.1 20.1 0.77 0.03
MHC r 47.9 France 26.2 1.0 6.5 0.6 0.72 0.04 0.77 0.01 3.1 2.8 3.5 0.4 0.3 0.5 8.4 5.6 12.6 0.74 0.02
Germany 19.5 1.1 3.3 0.4 0.82 0.04 0.83 0.01 4.7 4.2 5.3 0.2 0.2 0.3 21.2 12.7 35.3 0.82 0.02
Italy 24.8 0.8 3.4 0.3 0.79 0.04 0.77 0.01 3.4 3.1 3.8 0.3 0.2 0.4 12.5 7.8 20.2 0.78 0.02
The Netherlands 21.8 1.1 5.1 0.6 0.76 0.05 0.81 0.01 4.0 3.5 4.6 0.3 0.2 0.4 13.6 7.8 23.7 0.79 0.03
Spain 25.3 0.9 4.4 0.3 0.78 0.03 0.77 0.01 3.4 3.1 3.7 0.3 0.2 0.4 11.9 8.2 17.3 0.78 0.02
BRP-12 MHS r 41.9 Belgium 16.4 1.2 5.3 0.6 0.66 0.05 0.86 0.01 4.8 4.1 5.7 0.4 0.3 0.5 12.3 7.3 20.8 0.76 0.03
France 23.3 1.0 6.5 0.6 0.70 0.04 0.80 0.01 3.5 3.1 3.9 0.4 0.3 0.5 9.1 6.1 13.4 0.75 0.02
Germany 14.8 1.0 3.3 0.4 0.80 0.04 0.88 0.01 6.4 5.6 7.2 0.2 0.2 0.3 27.4 17.3 43.5 0.84 0.02
Italy 18.9 0.7 3.4 0.3 0.77 0.04 0.83 0.01 4.6 4.1 5.1 0.3 0.2 0.4 16.2 10.3 25.3 0.8 0.02
The Netherlands 17.5 1.0 5.1 0.6 0.70 0.05 0.85 0.01 4.8 4.1 5.6 0.4 0.3 0.5 13.5 8.1 22.5 0.78 0.03
Spain 17.1 0.7 4.4 0.3 0.71 0.04 0.85 0.01 4.9 4.4 5.4 0.3 0.3 0.4 14.4 10.2 20.4 0.78 0.02
Note. Estimates and standard errors (SEs) or 95% confidence interval.
AUC, area under the curve; BRP-12 MHS, Bidimensional Response Process Model Mental Health Score; CIDI 3.0, Composite International Diagnostic Interview, Version 3.0; DSM-IV, Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition; ESEMeD, European Study of the Epidemiology of Mental Disorders; Low, lower limit 95% confidence interval; LRþ, positive likelihood ratio; LR,
negative likelihood ratio; MCS-12, Original Mental Component Summary; RAND-12 MHC, RAND-12 Mental Health Composite; SE, standard error; SF-12v1, Short-Form 12 Health Survey, Version
1; Upp, upper limit 95% confidence interval.
* Depressive disorders: major depression episode or dysthymia based on DSM-IV criteria as assessed with the CIDI 3.0.
yPrevalence according to the SF-12 with the selected cutoff point.
zAUC for a dichotomous predictor (1 ¼ below or equal to the cutoff point; 0 ¼ above the cutoff point).
V
A
L
U
E
I
N
H
E
A
L
T
H
1
6
(
2
0
1
3
)
5
6
4
–
5
7
3
5
7
0
VA L U E I N H E A LT H 1 6 ( 2 0 1 3 ) 5 6 4 – 5 7 3 571method, however, has not been included in this article because its
rationale was close to that of the RAND-12 MHC, with spearman
correlation of 0.97 between them and both scoring methods
assuming that the mental and physical dimensions are correlated.
This study has some limitations that must be considered
when interpreting the results. First, the SF-12 was interviewer-
administered, while most typical form of the questionnaire is
self-administration. Several studies found that respondents tend
to report better health status in interviewer-administered surveys
than in self-administered interviews [30–32]. Second, measure-
ment invariance across countries has not been evaluated. How-
ever, average scores by country are consistent with previous
results for which no measurement bias regarding diagnostics
was found [33]. In addition, model fit for the BRP-12 is adequate,
which provides partial support to believe that the SF-12 does not
show serious noninvariance. Even though noninvariance in all
possible subgroups cannot be entirely ruled out by an isolated fit
index, it would be more likely if fit indexes were so poor as to
suggest that a different kind of model, affecting a subsample of
substantial size, could be underlying the full sample.
Despite these limitations, we are confident that the discrim-
inant capacity for 30-day depressive disorders observed in our
study is high, and it is similar to that of a study carried out in
Australia [4], which reported an AUC of 0.92 (95% CI 0.90–0.93) for
both the MCS-12 and the RAND-12 MHC to assess depression. In
addition, in that same study, a score of 45 or less was recom-
mended as the best screening cutoff for depression, with an SN of
0.87 and an SP over 0.80. Gill et al’s [4] results were based on CIDI
responses using ICD-10 criteria with a 4-week recall period. This
ensured the effective diagnosis of an active depressive episode at
the moment of the interview, which makes detection more likely.
It is important to note that when we use 12-month DSM-IV criteria,
the AUCs obtained for depressive disorders are still high, showing
that the mental component of the questionnaire is sensitive to the
presence of a recent disorder. Therefore, the SF-12 might be
adequate to discriminate among individuals with disorders even
though the pathology is not present anymore at the time of the
interview, or it is present with subthreshold symptomatology.
Our results are in the higher range of previous studies
conducted on the MCS of the SF-36. In a study carried out on a
representative sample of the US general population using the
SF-36 [34], an AUC of 0.77 was reported on the MCS of the SF-36
for the assessment of depressive disorders (major depression and/
or dysthymia), with an SN of 0.74 and an SP of 0.81 using the
cutoff point of 42. In other studies conducted on groups of
patients with the SF-36 [35–37], the AUC of detecting any mental
disorder was in the 0.82 to 0.91 range, with SN values between
0.73 and 1.0 and specificities between 0.64 and 0.90. It is important
to note, however, that in one of these studies [35] the presence of
disorder was assessed with the Centre for Epidemiological Studies
Depression (CES-D) Scale, a self-reported measure with 20 items
related to depressive symptomatology that does not follow stand-
ard diagnostic criteria such as the ICD or the DSM like the CIDI.
Results observed in our study are within the range of other
specific psychopathology scales based on symptoms that are
commonly used in general population epidemiologic surveys such
as the 12-item version of the General Health Questionnaire (GHQ-
12) or the CES-D Scale. In a review of validation studies using the
12-item version of the GHQ-12 to evaluate its screening ability for
common mental disorders, Goldberg et al. [38] reported SN values
ranging from 0.67 to 0.93 (median ¼ 0.84) and specificities ranging
from 0.59 to 0.91 (median ¼ 0.79). In the same study, results were
presented from primary care samples obtained in 15 centers
around the world, showing AUCs ranging from 0.83 to 0.95.
Similarly, screening performance of the CES-D against depressive
disorders has been found to be moderate to high in several studies,
with AUC values ranging between 0.74 and 0.94 [39–47].In our study, the discriminant capacity of the SF-12 to detect
individuals with depressive disorders is significantly greater than its
ability to detect anxiety disorders (with AUC values of 0.7 for both
12-month and 30-day recall periods). This is consistent with data
reported by Gill et al. [4] and may be explained by the fact that the
SF-12 contains two items related to symptoms in the affective
disorder spectrum, while only one of the symptoms relate to anxiety
disorders. Further work would be required to assess to what extent
the discriminant capacity of the SF-12 is due to these two items. The
discriminant capacity of the questionnaire for anxiety disorders,
however, increases substantially when we do not take into account
the disorders of social phobia and specific phobia in the count of
anxiety disorders, achieving AUC values of 0.77 for 12-month
disorders and 0.83 for 30-day disorders. We therefore do not
recommend SF-12 as a screener of anxiety disorders.
The optimal cutoff point for the mental component of the SF-
12 to screen for 30-day depressive disorders in Europe is 45.6 for
the MCS-12 score. This cutoff point is substantially higher than
the score of 42 or less suggested for the mental component of the
SF-36 in the US general population to detect depressive disorders
according to the Diagnostic Interview Schedule [34]. However,
both values are about 8 points below the respective general
population mean (i.e., 53.7 in Europe and 50 in the United States),
and the accuracy achieved in the EU sample with the suggested
cutoff point (SN ¼ 0.86, SP ¼ 0.88) is better than that achieved in
the US sample (SN ¼ 0.74, SP ¼ 0.81). These performance results
imply that when administered to the general European popula-
tion, the SF-12 will miss only 14% of the true cases (SN ¼ 0.86),
while it will identify as depressed 12% of the individuals who
would not comply with diagnostic criteria (SP ¼ 0.88).
The ESEMeD sample was selected to be representative of the
adult general population of each country. In addition, poststrati-
fication weights were used to restore the slight differences
encountered in the distributions of age, gender, and region within
each country as compared with those of the general population
[13]. Thus, we are reasonably convinced that the cutoff point
suggested here is adequate for its use in the six countries studied.
Further research, however, is needed to determine whether this
cutoff point could be adequately used in other countries.
The cutoff point suggested for the RAND-12 MHC to assess 30-
day depressive disorders is 44.5, while for the BRP-12 MHS it is 40.2.
Similar to what has been described for the MCS-12, these cutoff
points are 8.4 and 9.8 points below the corresponding general
population mean, respectively. Such consistency would support
the use of the cutoff points described in our study. Nevertheless, it
is important to stress that these cutoff points are not directly
comparable, because the MCS-12 and RAND-12 MHC are norm-
based scores with a mean of 50 in the US general population, and
mean scores in our sample are higher (mean MCS-12 ¼ 53.7 and
mean RAND-12 MHC ¼ 52.9), while BRP-12 MHS are T-scored to
have a mean of 50 in our sample. To be able to compare them,
specific methods of scale linking based on equipercentile curves or
linear linking should be applied, which goes beyond the scope of
this article. Moreover, comparisons of the three scoring methods
using equipercentile curves have already been applied previously
on the same sample (Forero et al., under review).Conclusions
Results of this large study show that in spite of not having been
developed as a screening questionnaire, the mental component
of the SF-12 performs adequately as a measure of active and
recent depressive disorders in the adult general population. The
SF-12 is sensitive enough to active and recent depressive disor-
ders, and its accuracy is at a similar level as that of other
screening measures specifically developed for the detection of
VA L U E I N H E A LT H 1 6 ( 2 0 1 3 ) 5 6 4 – 5 7 3572depressive disorders, such as the CES-D scale. Thus, the SF-12
can be confidently used as a screening measure for these
disorders for prevalence monitoring and targeting treatment
from general population surveys, such as health interview
surveys, in which this instrument is usually included.
For depressive disorder detection purposes, and whenever US
norms are used to obtain the MCS-12 in Europe, the cutoff point
of 45.6 is recommended over the US general population SF-36
cutoff point of 42. The European cutoff provides specific results
due to better fit to population characteristics.Acknowledgments
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